The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The Pharmacodynamics of L-Arginine
Open accessAbstract
L-arginine is a precursor for nitric oxide (NO) synthesis. NO is a ubiquitous mediator that is formed by a family of enzymes named NO synthases. In the brain, NO acts as a neurotransmitter; in the immune system, NO acts as a mediator of host defense; and in the cardiovascular system, NO mediates the protective effects of the intact endothelium, acting as a vasodilator and endogenous antiatherogenic molecule. About 5 g of L-arginine is ingested each day in a normal Western diet. L-arginine plasma levels are not significantly reduced in most disease conditions, except end-stage renal failure during hemodialysis treatment. Nonetheless, intravenous or dietary (oral) administration of relatively large doses of L-arginine has been shown to result in enhanced NO formation in subjects with impaired endothelial function at baseline. In several controlled clinical trials, long-term administration of L-arginine has been shown to improve the symptoms of cardiovascular disease. However, in other trials L-arginine was not beneficial, and in a recent study, the authors reported higher mortality of subjects receiving L-arginine than those receiving placebo. Recently it became clear that endogenous levels of asymmetric dimethylarginine (ADMA), a competitive inhibitor of L-arginine metabolism by NO synthase, may determine a subject's response to L-arginine supplementation. L-arginine appears to exert no effect in subjects with low ADMA levels, whereas in subjects with high ADMA levels, L-arginine restores the L-arginine/ADMA ratio to normal levels and thereby normalizes endothelial function. In conclusion, the effects of L-arginine supplementation on human physiology appear to be multicausal and dose-related. Doses of 3-8 g/d appear to be safe and not to cause acute pharmacologic effects in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As pointed out above, the ratio of l-arginine to ADMA appears to be a better indicator of cardiovascular risk (28, 103, 104, 606, 1050).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [103]
In the citing paper
“It has been noted that when ADMA levels are low, the effects of exogenous l-arginine are limited; however, the therapy seems to be more beneficial in patients with higher ADMA levels, in which the treatment increases the l-arginine/ADMA ratios and improves endothelial function (103).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,122
Drexler, H., Zeiher, A. M., Meinzer, K., & Just, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92372-9 · Cited by 794
NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, J. P., & Dzau, V. J. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 706
Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III)
Förstermann, U., Boissel, J., & Kleinert, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.773 · Cited by 647
Berkowitz, D. E., White, R., Li, D., Minhas, K. M., Cernetich, A., Kim, S., Burke, S., Shoukas, A. A., Nyhan, D., Champion, H. C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000092948.04444.c7 · Cited by 486
LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells
Böger, R. H., Sydow, K., Borlak, J. T., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode‐Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 478
Self-citationNitric oxide and atherosclerosis: An update
Claudio Napoli, A., de Nigris, F., Williams‐Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.03.011 · Cited by 471
THE NUTRITIVE SIGNIFICANCE OF THE AMINO ACIDS
Rose, W. C. (1938) · Physiological Reviews · doi:10.1152/physrev.1938.18.1.109 · Cited by 462
McEniery, C. M., Wallace, S. M. L., Mackenzie, I. S., McDonnell, B. J., Yasmin, Y., Newby, D. E., Cockcroft, J. R., & Wilkinson, I. B. (2006) · Hypertension · doi:10.1161/01.hyp.0000239206.64270.5f · Cited by 416
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
Böger, R. H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00500-5 · Cited by 393
Self-citationArginine is a physiological precursor of endothelium-derived nitric oxide
Schmidt, H. H. H. W., Nau, H., Wittfoht, W., Gerlach, J. C., Prescher, K.-E., Klein, M. M., Niroomand, F., & Böhme, E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90101-x · Cited by 389
Xu, W., Kaneko, F. T., Zheng, S., Comhair, S. A. A., Janocha, A. J., Goggans, T., Thunnissen, F. B. J. M., Farver, C., Hazen, S. L., Jennings, C., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2317fje · Cited by 369
Lee, J.-H., Ryu, H., Ferrante, R. J., Morris, S. M., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0735876100 · Cited by 365
Enzymes of Arginine Metabolism
Morris, S. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2743s · Cited by 361
Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., et al. (2006) · JAMA · doi:10.1001/jama.295.1.58 · Cited by 357
Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats.
Böhme, G. A., Bon, C. L. M., Lemaire, M., Reibaud, M., Piot, O., Stutzmann, J. M., Doble, A., & Blanchard, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9191 · Cited by 341
The Clinical Pharmacology of L-Arginine
Böger, R. H., & Bode‐Böger, S. M. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 337
Self-citationRector, T. S., Bank, A. J., Mullen, K. A., Tschumperlin, L. K., Sih, R. T., Pillai, K., & Kubo, S. H. (1996) · Circulation · doi:10.1161/01.cir.93.12.2135 · Cited by 275
L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship
Bode‐Böger, S. M., Böger, R. H., Galland, A., Tsikas, D., & Frölich, J. C. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00803.x · Cited by 258
Self-citationDetermination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay
Schulze, F., Wesemann, R., Schwedhelm, E., Sydow, K., Albsmeier, J., Cooke, J. P., & Böger, R. H. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.257 · Cited by 252
Self-citationAsymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
Böger, R. H. (2006) · Annals of Medicine · doi:10.1080/07853890500472151 · Cited by 238
Self-citationProtein digestion and amino acid and peptide absorption
Silk, D. B. A., Grimble, G., & Rees, R. G. (1985) · Proceedings of The Nutrition Society · doi:10.1079/pns19850011 · Cited by 223
Oral L-arginine improves endothelial function in healthy individuals older than 70 years
Bode‐Böger, S. M., Muke, J., Surdacki, A., Brabant, G. E., Böger, R. H., & Frölich, J. C. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm474oa · Cited by 198
Self-citationl -Arginine Induces Nitric Oxide–Dependent Vasodilation in Patients With Critical Limb Ischemia
Bode‐Böger, S. M., Böger, R. H., Alfke, H., Heinzel, D., Tsikas, D., Creutzig, A., Alexander, K., & Frölich, J. C. (1996) · Circulation · doi:10.1161/01.cir.93.1.85 · Cited by 196
Self-citationZhang, C., Hein, T. W., Wang, W., Miller, M. W., Fossum, T. W., McDonald, M. M., Humphrey, J. D., & Kuo, L. (2004) · Hypertension · doi:10.1161/01.hyp.0000146907.82869.f2 · Cited by 194
Nitric Oxide in the Central Nervous System
Paakkari, I., & Lindsberg, P. J. (1995) · Annals of Medicine · doi:10.3109/07853899509002590 · Cited by 189
Effect of Supplemental Oral l-Arginine on Exercise Capacity in Patients With Stable Angina Pectoris
Ceremuzyński, L., Chamiec, T., & Herbaczyńska-Cedro, K. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00354-8 · Cited by 173
The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications
Böger, R. H., Bode‐Böger, S. M., & Frölich, J. C. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05953-9 · Cited by 168
Self-citationOral l -Arginine in Patients With Coronary Artery Disease on Medical Management
Blum, A., Hathaway, L., Mincemoyer, R., Schenke, W. H., Kirby, M., Csákó, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.18.2160 · Cited by 162
The vascular effects of L-Arginine in humans. The role of endogenous insulin.
Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Coppola, L., Cozzolino, D., & D'Onofrio, F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119177 · Cited by 159
Determination of a reference value for NG, NG‐dimethyl‐L‐arginine in 500 subjects
Schulze, F., Maas, R., Freese, R., Schwedhelm, E., Silberhorn, E., & Böger, R. H. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01561.x · Cited by 154
Self-citationArginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells
Chicoine, L. G., Paffett, M. L., Young, T. L., & Nelin, L. D. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00194.2003 · Cited by 152
Bode‐Böger, S. M., Böger, R. H., Creutzig, A., Tsikas, D., Gutzki, F. M., Alexander, K. G., & Frölich, J. C. (1994) · Clinical Science · doi:10.1042/cs0870303 · Cited by 148
Self-citationKilbourn, R. G., Szabó, C., & Trabers, D. L. (1997) · Shock · doi:10.1097/00024382-199704000-00001 · Cited by 146
Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man.
Castillo, L., deRojas-Walker, T., Chapman, T. E., Vogt, J., Burke, J. F., Tannenbaum, S. R., & Young, V. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.193 · Cited by 133
Bogle, R., MacAllister, R. J., Whitley, G. S. J., & Vallance, P. J. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.3.c750 · Cited by 132
Plasma Growth Hormone after Arginine Infusion
Merimee, T. J., Rabinowitz, D. L., Riggs, L., Burgess, J. A., Rimoin, D. L., & McKusick, V. A. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702232760803 · Cited by 129
Schwedhelm, E., Tan-Andresen, J., Maas, R., Riederer, U., Schulze, F., & Böger, R. H. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046037 · Cited by 122
Self-citationPharmacotherapies and their influence on asymmetric dimethylargine (ADMA)
Maas, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm605oa · Cited by 113
Walker, H. A., McGing, E., Fisher, I. B., Böger, R. H., Bode‐Böger, S. M., Jackson, G., Ritter, J. M., & Chowienczyk, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01380-8 · Cited by 112
Self-citationBöger, R. H., & Ron, E. S. (2005) · PubMed · Cited by 112
Self-citationArginase pathway in human endothelial cells in pathophysiological conditions
Bachetti, T. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.004 · Cited by 105
Calver, A., Collier, J., Leone, A., Moncada, S., & Vallance, P. J. (1993) · PubMed · Cited by 100
Arginine metabolism in vascular biology and disease
Morris, S. M. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000112 · Cited by 85
Zembowicz, A., Hecker, M., Macarthur, H., Sessa, W. C., & Vane, J. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11172 · Cited by 72
The pivotal role of nitric oxide for vascular health.
Cooke, J. P. (2004) · PubMed · Cited by 65
Bednarz, B., Jaxa-Chamiec, T., Maciejewski, P., Szpajer, M., Janik, K., Gniot, J., Kawka‐Urbanek, T., Drozdowska, D., Gessek, J., & Laskowski, H. (2005) · PubMed · Cited by 64
Böger, R. H., Tsikas, D., Bode‐Böger, S. M., Phivthong‐ngam, L., Schwedhelm, E., & Frölich, J. C. (2004) · Nitric Oxide · doi:10.1016/j.niox.2004.07.008 · Cited by 56
Self-citationEffect of Aging on Free Amino Acids and Electrolytes in Leg Skeletal Muscle
Möller, P., Bergström, J. P., Eriksson, S., Fürst, P., & Hellström, K. (1979) · Clinical Science · doi:10.1042/cs0560427 · Cited by 49
L-arginine supplementation prolongs exercise capacity in congestive heart failure.
Bednarz, B., Jaxa-Chamiec, T., Gebalska, J., Herbaczyńska-Cedro, K., & Ceremuzyński, L. (2004) · PubMed · Cited by 48
Bode‐Böger, S. M., Böger, R. H., Löffler, M., Tsikas, D., Brabant, G. E., & Frölich, J. C. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700107 · Cited by 43
Self-citationReduced plasma L-arginine in hypercholesterolaemia
Jeserich, M., Münzel, T. F., Just, H., & Drexler, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90389-k · Cited by 42
Bednarz, B., Wolk, R. A., Chamiec, T., Herbaczyńska-Cedro, K., Winek, D., & Ceremuzyński, L. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00324-7 · Cited by 34
Electrolytes and Free Amino Acids in Leg Skeletal Muscle of Young and Elderly Women
Möller, P., Alvestrand, A., Bergström, J. P., Fürst, P., & Hellström, K. (2009) · Gerontology · doi:10.1159/000213088 · Cited by 31
Nitric Oxide, Caveolae, and Vascular Pathology
Li, X., Everson, W. V., & Smart, E. J. (2006) · Cardiovascular Toxicology · doi:10.1385/ct:6:1:1 · Cited by 30
Rh, B., Mügge, A., Bode‐Böger, S. M., Heinzel, D., Mm, H., & Frölich, J. C. (1996) · PubMed · Cited by 27
Dudek, D., Legutko, J., Heba, G., Bartuś, S., Partyka, Ł., Huk, I., Dembinska-Kiec, A., Kałuża, G. L., & Dubiel, J. S. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.025 · Cited by 17
Arginine Therapy for Acute Myocardial Infarction
Abumrad, N. N., & Barbul, A. (2006) · JAMA · doi:10.1001/jama.295.18.2138-b · Cited by 12
Letter to the editor re: JAMA article on L-arginine therapy in acute myocardial infarction.
Böger, R. H. (2006) · PubMed · Cited by 4
Self-citation
Research works printed but not linked: 2
- Bode-Böger, 1998, Pharmacokinetic-pharmacodynamic relationship of the effects of intravenous and oral L-arginine on nitric oxide formation and peripheral haemodynamics in healthy human subjects, Br J Clin Pharmacol., 46, 489
- Maas, 2005, Pharmacotherapeutic interventions and their influence on ADMA levels, Vasc Med., 10, S49, 10.1177/1358836X0501000108 · DOI
Cited by
Sorted by citations
Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Myeloid Cell-Derived Arginase in Cancer Immune Response
Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzyńska, Z., Jasiński, M., Nowis, D., & Gołąb, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00938 · Cited by 446
Arginine de novo and nitric oxide production in disease states
Luiking, Y. C., Have, G. A. M. T., Wolfe, R. R., & Deutz, N. E. P. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00284.2012 · Cited by 250
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
Wen, H., Deng, H., Li, B., Chen, J., Zhu, J., Zhang, X., Yoshida, S., & Zhou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02044-3 · Cited by 284
Metadata
- Authors
- Böger, R. H.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Böger, Rainer H.
- ORCID
- Böger, Rainer H.
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 137
- Issue
- 6
- Pages
- 1650S-1655S
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2115875498
- Cited by
- 221
- References
- 61
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 10 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 14 · 2017: 11 · 2016: 16 · 2015: 11 · 2014: 12 · 2013: 13 · 2012: 12
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Deutsche Herzstiftung
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Keywords
- L-arginine, nitric oxide, nitric oxide synthase, asymmetric dimethylarginine, endothelial function, cardiovascular disease, dietary supplementation, pharmacodynamics, dose-response relationship, end-stage renal disease, vasodilation, antiatherogenic effects
- MeSH terms
- Arginine, Cardiovascular Diseases, Humans, Nitric Oxide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
